Last updated: October 24, 2026
By Dave Manchester, Scientific Recruiting, KORE1
A 483 lands on a Friday. How many of the observations on it can your own quality team clear, and how many need hands you don’t have yet? FDA asks for a written response within 15 business days if you want it considered before the agency decides on further action. Write the response with your own quality leaders, then contract the long tail: investigations, CAPA execution, SOP rewrites, and retraining, billed hourly so the team shrinks as observations close. Data as of October 2026.
One thing before we go further. KORE1 is a staffing firm, this page ends with a way to hire through us, and I run the desk that fills these seats. Take that for what it’s worth. Devin Hornick, who sets priorities for what we cover here, told me the pieces worth writing are for clients in spots “where companies simply can’t afford to have projects fail or go unfinished.” A site mid-483 qualifies. I’ll still tell you plainly which parts of a 483 response you should never hand to a contractor, because getting that wrong is worse than a slow remediation.
Most of what gets written about FDA Form 483s is legal advice. Good legal advice, usually. What it skips is the staffing question underneath it: once your quality leaders know what the response has to say, who actually does the work of saying it, running the investigations behind it, and clearing the backlog before the next inspection? That’s the part I can answer. Not legal strategy. Staffing.
What a 483 Actually Starts, and What the 15-Day Clock Covers
An FDA Form 483 lists the conditions an investigator observed during an inspection that, in their judgment, may violate the Food, Drug and Cosmetic Act. It isn’t a final finding. It’s a list, handed to your management team at the end of the visit, that you’re expected to respond to in writing.
Here’s where people get the clock wrong. The 15 business days doesn’t come from a statute. It comes from a 2009 FDA notice in the Federal Register that set up a program for how the agency handles warning letters. Under it, FDA will generally hold off on issuing a warning letter to consider a response received within 15 business days of the 483. Send yours on day 20 and nothing illegal happened. You’ve just lost your shot at having it weighed before the agency decides what comes next.
Response and completion are two different clocks, and this is where a lot of sites waste a month arguing with themselves. You do not need every CAPA closed, every retest run and every SOP rewritten inside 15 days. Nobody does. What you need is a plan that’s written, specific, and credible: what you found, why it happened, what you’re doing about it, and by when. FDA’s own FAQ on the Form 483 says more or less that, calling for a corrective action plan implemented expeditiously. Not a finished product on day 15. Nobody expects that either.
A warning letter is a different animal. It gets reserved for violations FDA decides weren’t promptly and adequately corrected, and yes, one can still land after a response written in good faith. The 15-day window isn’t immunity. It’s a better hearing.
Who Writes the Response, Who Clears the List Behind It
Your head of quality writes the response. Your site head and regulatory affairs lead sign it. Every date in there, every scope statement, is a promise your company just made to a federal agency, and that part never gets contracted out. Not to me. Not to anyone carrying a W2 from a staffing firm.
Almost everything the response then commits you to doing, though, can be. Investigations into whatever discrepancy the 483 flagged. CAPA execution, once somebody with real authority signs off on the root cause. A pile of document control work, because remediation generates paperwork faster than most quality departments can file it on a good day. Retraining, if the finding traces back to a gap in who knew what. Sometimes retesting, if it traces back to a method instead of a person.
Devin Hornick, who runs strategy here at KORE1, puts it this way when clients ask how this is different from hiring a consulting firm: “In the SOW world, this is just a hiring manager with a budget, going outside and hiring something and saying, I have this to get done and I need you to do it.” We staff it hourly. “Hourly, which we prefer,” he told me. “It’s really more of a staffing model to do the hourly billing and you manage the person.” Compare that to a fixed-fee project, and the difference matters: “generally staffing firms don’t get into that,” Devin said. “That’s a professional services thing. That’s a consulting group thing.”
Why does that distinction matter to you, specifically, mid-remediation? Because a fixed-fee consulting engagement prices the whole project up front and somebody eats the overrun if the investigations run long, which they usually do. An hourly contract seat costs what it costs for the hours it’s used, and it rolls off the day the work is done. If observation six closes in week three instead of week six, you stop paying for observation six in week three.
Which Seat Goes Where
FDA publishes the areas of regulation cited on 483s every fiscal year. In the FY 2025 drug-inspection dataset, the single most-cited observation area for drug manufacturers was quality control unit procedures under 21 CFR 211.22, cited 243 times. Second was investigations of discrepancies and failures under 21 CFR 211.192, cited 164 times. Those two sections alone explain most of what a remediation team spends its hours on. No surprise there.
Equipment and calibration issues under 211.68 and training gaps under 211.25 show up often enough to staff for, but at lower volume. Records problems under 211.186 and 211.188 round out the list, usually as a symptom of one of the bigger four rather than a standalone finding.
| Observation Area | Contract Seat | Internal Owner | Hourly Contract Fit |
|---|---|---|---|
| QC unit responsibilities (21 CFR 211.22) | Contract batch record reviewer | QC unit manager; final release stays internal | High. Bounded backlog, defined procedures. |
| Investigations of discrepancies (21 CFR 211.192) | Contract investigator or CAPA owner | Head of quality approves root cause and closure | High. Surge work with a finite list. |
| Training (21 CFR 211.25) | Contract GMP trainer | Site head confirms curriculum and scope | Medium. Tapers once records catch up. |
| Laboratory controls (21 CFR 211.160) | Contract QC analyst for retesting | QC unit sets and approves specifications | High. Volume bounded by retest count. |
| Equipment and calibration (21 CFR 211.68) | Contract calibration or metrology technician | Engineering or QC approves qualification | Medium. Often partly vendor-serviced already. |
Two observations on one 483 rarely need the same seat twice. A document control specialist clearing a records backlog and an investigator chasing down why a batch failed its yield check are different skill sets wearing the same “quality contractor” label on an org chart. Staff them as different people.
How Fast Contract Staff Can Actually Start
Across 1,997 KORE1 contract placements from 2019 to 2026, the median time from offer to start was 3 days, and 86% started within a week. That’s across all roles, not lab and QC specifically, so treat it as a planning floor, not a promise for your site.
A few things push it past 3 days for a 483 remediation specifically. Site badging. GMP and site-specific SOP training before anyone touches a batch record. Background and drug screens, if your site requires them beyond what the contractor’s staffing firm already ran. None of that is a reason to wait to start sourcing. It’s a reason to start sourcing the day the 483 is issued, not the day the response is due.
No contractor is guaranteed to land on a specific date, and I’m not going to tell you otherwise. What I can tell you is that the search starts the moment you call, not the moment you sign a statement of work.
What a Remediation Team Costs per Week
Document control and lab seats for a 483 remediation sit inside KORE1’s broader lab, QC and life-sciences placement range: $33 to $56 an hour, with a median of $40, across 54 W2 contract placements since 2019. I wrote up the full breakdown, including how that compares to published wage data, on our lab and QC contractor bill rate page. At 40 hours a week, that’s roughly $1,320 to $2,240, with $1,600 landing in the middle.
Investigators and CAPA owners usually price above that family, because the work calls for root-cause method, not just document throughput. The spread between a document control seat and an investigator isn’t padding, either, since the investigator is the one standing in front of a batch record working out why a yield came in short, defending that conclusion to your quality unit, and writing it up in language that still holds up if FDA reads it eighteen months from now. I’m not going to hand you a made-up number for that seat. Send me the observation and I’ll price it against real placements, not a guess.
That bill rate is all-in. It already carries the employer taxes, insurance, sick pay, and payroll administration that come with employing someone, which is a different list than what shows up on the contractor’s own paycheck. One number, on one invoice. And it’s hourly the whole way through, never a fixed project fee, because a remediation team’s hours shrink every week observations close, and a fixed-fee contract has no mechanism for that.
What You Can’t Hand to a Contractor
Three things stay with your team, full stop.
Authorship. The words in the 483 response are your company’s words, and FDA will hold your company to them.
Commitments. Every date and every scope statement in that response is a promise. A contractor can draft language for your head of quality to edit, but the signature belongs to someone on your payroll.
Release approval. Your quality control unit approves or rejects batches, under 211.22. A contractor can review, recommend and flag. The approval stays internal, every time, no exceptions.
There’s no guarantee attached to any of this, on either side. There’s no guarantee a contractor fills every seat on your timeline, and there’s no guarantee staffing up gets you past the next inspection clean. What staffing up gets you is bandwidth. The judgment calls remain yours.
Shrink the Team as the List Shrinks
Say the quiet part early. A remediation team that never gets smaller is a sign something’s wrong, either with the work or with how it’s staffed. Build the wind-down into the plan from week one, not week twelve.
Here’s roughly how it goes. Investigations close first, usually in the first month or two, because most root causes aren’t actually mysterious once someone has the hours to chase them. Document control tapers next, once the backlog it was hired to clear is cleared. Retraining is often the last seat standing, because training effectiveness checks need a few production cycles to prove out before anyone signs off on “fixed.”
If one seat on the team turns out to be permanent work and not remediation work, that’s worth a direct conversation, not a renewal. KORE1 charges no conversion fee after 1,040 hours on a contract seat, which is roughly six months at 40 hours a week. If your CAPA effectiveness monitoring needs to live somewhere after the remediation ends, converting the contractor who already knows your batch records usually beats starting a new search from zero.
What Quality Leaders Ask After a 483
Is 15 business days a hard legal deadline?
No. It’s a window FDA set itself in a 2009 Federal Register notice for whether a response gets weighed before a warning letter decision, not a statutory requirement.
Miss it and you haven’t broken a law. You’ve just removed your response from consideration on the agency’s normal timeline, which raises the odds the next letter you get is a warning letter instead of a conversation.
What happens if our response takes longer than 15 days?
You still send it, even late. FDA may issue a warning letter in the meantime regardless, and a late response doesn’t undo anything already in motion.
Send a partial response by day 15 if the full one isn’t ready: what you’ve confirmed, what’s still under investigation, and a realistic date for the rest. A partial response inside the window beats a complete one outside it.
Can a contract investigator sign off on a CAPA?
They can draft the root cause and recommend the corrective action. Final CAPA approval sits with your quality unit, the same people accountable for the batch disposition decisions that depend on it.
Plenty of sites blur this line under deadline pressure. Don’t. It’s the fastest way to turn one 483 finding into two.
Do we need one firm for every seat, or can we mix specialists?
Mix them. An investigator, a document control specialist and a trainer are different skill sets, and treating a remediation as one blanket “quality staffing” order usually means at least one of those seats gets filled by someone wrong for it.
What if the 483 turns into a warning letter while we’re still staffing up?
A warning letter doesn’t restart your remediation from zero. Usually it just means FDA wants the same corrective actions, written up more thoroughly, on a schedule the agency is now watching closer.
Keep executing the plan you already built. Don’t rewrite it from scratch. That costs more time than the letter did.
Map the Seats Before You Hire Anyone
Send me your observation areas. Redacted is fine. Add your response due date, your site city, and whether your team is already GMP-trained or needs that covered too, and I’ll map which seats are worth contracting and which stay on your own payroll.
A few places to go from here, depending on what you’re actually staring at. If this is turning into a standing team rather than a one-time surge, our FDA 483 remediation staffing page covers that version. Need the hire outside a remediation window entirely? Pharmaceutical staffing and quality control staffing cover those seats. Trying to sort out who owns QC work versus who signs off as QA? I wrote about the QC versus QA split separately. And if the finding is really a documentation gap, go look at who reviews and releases your batch records, because that’s probably the seat you’re missing.
Hourly or contract the whole way through. Neither one requires hiring anyone permanently just to get through this.
When you’re ready, Let’s Connect. Expert in finding you the right talent, right away. You can also find me on LinkedIn.
